Business Context and Reporting Period
Company: GP-Act III Acquisition Corp. (GPAT)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended March 31, 2025
Business Overview: The Company is a Cayman Islands exempted company and a "blank check" SPAC formed to effect a merger, share exchange, or asset acquisition with one or more target businesses. As of March 31, 2025, the Company had not commenced any operations. All activity relates to its formation, its Initial Public Offering (IPO) consummated on May 13, 2024, and the search for a business combination. The Company has 24 months from the IPO closing (until May 13, 2026) to complete a business combination or face mandatory liquidation.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Income (Loss) | $2,907,329 | $(59,738) |
| Revenue | $0 | $0 |
| Operating Expenses | $200,052 | $59,738 |
| Interest Income (Trust Account) | $3,107,381 | $0 |
| Cash and Cash Equivalents | $376,572 | $153,197 |
| Marketable Securities in Trust Account | $299,844,019 | $0 |
| Total Assets | $300,487,903 | $0 (Pre-IPO) |
| Total Liabilities | $14,776,019 | $0 (Pre-IPO) |
| Working Capital Deficit | $(156,302) | N/A |
| Shares Outstanding (Class A) | 28,750,000 | 0 |
| Shares Outstanding (Class B) | 7,187,500 | 7,187,500 |
Material Changes vs. Prior Period
- Post-IPO Status: The most significant change is the Company's transition from a pre-IPO entity to a public SPAC following the IPO on May 13, 2024. Consequently, Q1 2024 reflects pre-IPO organizational costs with no trust assets, while Q1 2025 reflects post-IPO operations.
- Net Income: The Company reported a net income of $2.9 million in Q1 2025, compared to a net loss of $59,738 in Q1 2024. This shift is driven entirely by interest income earned on the Trust Account ($3.1 million), which did not exist in the prior period.
- Operating Expenses: General and administrative expenses increased to $200,052 in Q1 2025 from $59,738 in Q1 2024, reflecting the costs of maintaining a public company and searching for a target.
- Trust Account Growth: The Trust Account balance grew from $296.7 million at year-end 2024 to $299.8 million at March 31, 2025, due to accrued interest.
Outlook, Risks, and Management Commentary
- Liquidity and Going Concern: The Company has a working capital deficit of $156,302 and holds $376,572 in operating cash. Management has determined that the mandatory liquidation date (May 13, 2026) raises substantial doubt about the Company's ability to continue as a going concern. The Company may need to raise additional capital through loans from sponsors or third parties to meet working capital needs.
- Business Combination Deadline: The Company must complete a business combination by May 13, 2026. Failure to do so will trigger an automatic winding up, dissolution, and liquidation, with funds in the Trust Account distributed to shareholders.
- Deferred Fees: The Company has significant deferred liabilities, including $13,687,500 in deferred underwriting fees and $350,000 in deferred legal fees, payable only upon the successful completion of a business combination.
- Risk Factors: Risks include geopolitical instability (Russia-Ukraine, Israel-Hamas conflicts) affecting global markets, the inability to secure a business combination within the 24-month window, and the potential inability to obtain additional financing if needed.
Investor Verification Checklist
- Trust Account Balance: Verify the current redemption value per share ($10.43 as of March 31, 2025) and the total interest earned to date.
- Extension Options: Confirm if the Company has the ability to extend the 24-month combination period and the associated costs or shareholder vote requirements.
- Related Party Loans: Review the outstanding balances of promissory notes ($400,000) and advances ($44,938) from related parties and their terms regarding repayment or conversion.
- Working Capital Runway: Assess the sufficiency of the $376,572 operating cash balance against the monthly administrative fee ($5,000) and other operating expenses to determine the likelihood of needing additional sponsor funding.
- Deferred Underwriting Fee: Note the $13.7 million deferred fee liability that will reduce the net proceeds available to the combined entity upon a successful merger.